Sign inJoin waitlistJoin the waitlist

Jianguo Tao

Professor, Pathology · University of Virginia Medical Center

Credentials: · · · · · ·

History

University of Virginia Medical Center
Present
University of Virginia Medical Center
Present

Hematology
1998–1999
University of Pennsylvania Medical Center
1997–1998
Internal Medicine
1994–1997
Pathology
Long Island Jewish Medical Center - Northwell Health
1990–1994
Peking Medical University
1986–1990

Research

Induction of myelodysplasia by myeloid-derived suppressor cells
Journal of Clinical Investigation · 2013 · 283 citations
microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma
Blood · 2010 · 282 citations
Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory…
Cancer Research · 2003 · 249 citations

Eduardo Sotomayor
25 papers
LM
Lynn Moscinski
18 papers
WD
William Dalton
15 papers
BS
Bijal Shah
11 papers
KB
Kapil Bhalla
10 papers
KS
Kenneth Shain
9 papers
Javier Pinilla-Ibarz
6 papers
KF
Kai Fu
5 papers
SD
Sophie Dessureault
5 papers
Karrune Woan
3 papers · 1 as a resident
Adam Bagg
2 papers
AS
Andrew Savoie
2 papers

Grants

New Therapeutic Vulnerabilities for Aggressive B-Cell Lymphoma
National Cancer Institute · R01
Contact PI · $554.7K · h. Lee Moffitt Cancer Ctr & Res Inst
2020–2025
Transcriptional and Epigenetic Adaptation as Novel Therapeutic Vulnerabilities for Mantle Cell Lymphoma
National Cancer Institute · R01
Contact PI · $513.4K · h. Lee Moffitt Cancer Ctr & Res Inst
2020–2025
Epigenetic Regulation of Drug Resistance to ABT-199 in B-Cell Malignancies
National Cancer Institute · R21
Contact PI · $224.5K · h. Lee Moffitt Cancer Ctr & Res Inst
2019–2021
Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy
National Cancer Institute · R01
PI · $1.8M · George Washington University
2015–2020